These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 25069659)

  • 1. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
    Blair LJ; Sabbagh JJ; Dickey CA
    Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 activator Aha1 drives production of pathological tau aggregates.
    Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Crystal Structure of the Hsp90-LA1011 Complex and the Mechanism by Which LA1011 May Improve the Prognosis of Alzheimer's Disease.
    Roe SM; Török Z; McGown A; Horváth I; Spencer J; Pázmány T; Vigh L; Prodromou C
    Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
    Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
    J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.
    Batko J; Antosz K; Miśków W; Pszczołowska M; Walczak K; Leszek J
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones.
    Iqbal M; Lewis SL; Padhye S; Jinwal UK
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges.
    He C; Gu J; Wang D; Wang K; Wang Y; You Q; Wang L
    Eur J Med Chem; 2023 Dec; 261():115859. PubMed ID: 37839344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp multichaperone complex buffers pathologically modified Tau.
    Moll A; Ramirez LM; Ninov M; Schwarz J; Urlaub H; Zweckstetter M
    Nat Commun; 2022 Jun; 13(1):3668. PubMed ID: 35760815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1.
    Peak SL; Gracia L; Lora G; Jinwal UK
    Neuroscience; 2021 Jan; 453():312-323. PubMed ID: 33246057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.
    Woo JA; Liu T; Zhao X; Trotter C; Yrigoin K; Cazzaro S; Narvaez E; Khan H; Witas R; Bukhari A; Makati K; Wang X; Dickey C; Kang DE
    Hum Mol Genet; 2017 Oct; 26(20):3973-3988. PubMed ID: 29016855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?
    Luo W; Rodina A; Chiosis G
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S7. PubMed ID: 19090995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 90 in Alzheimer's disease.
    Ou JR; Tan MS; Xie AM; Yu JT; Tan L
    Biomed Res Int; 2014; 2014():796869. PubMed ID: 25374890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
    Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
    Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
    Gorantla NV; Chinnathambi S
    J Mol Neurosci; 2018 Nov; 66(3):356-368. PubMed ID: 30267382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.
    Jinwal UK; Trotter JH; Abisambra JF; Koren J; Lawson LY; Vestal GD; O'Leary JC; Johnson AG; Jin Y; Jones JR; Li Q; Weeber EJ; Dickey CA
    J Biol Chem; 2011 May; 286(19):16976-83. PubMed ID: 21367866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting.
    Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau triage decisions mediated by the chaperone network.
    Cook C; Petrucelli L
    J Alzheimers Dis; 2013; 33 Suppl 1():S145-51. PubMed ID: 22596270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stressing Out Hsp90 in Neurotoxic Proteinopathies.
    Inda C; Bolaender A; Wang T; Gandu SR; Koren J
    Curr Top Med Chem; 2016; 16(25):2829-38. PubMed ID: 27072699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.
    Blair LJ; Baker JD; Sabbagh JJ; Dickey CA
    J Neurochem; 2015 Apr; 133(1):1-13. PubMed ID: 25628064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.